This study underscores the longer-term late effects among this aging cohort of childhood cancer survivors reaching their sixth and seventh decades of life,” the researchers wrote.

Surrogate endpoints increasingly are used for cancer drug approvals, but it’s not clear if these endpoints correlate with clinical benefit.

Medicare Part D plans increased cost-sharing through higher deductibles and greater reliance on coinsurance for nonspecialty, brand-name drugs,” the researchers wrote.

Certain symptoms of chemotherapy are associated with an increased risk of emergency department (ED) visits and inpatient hospital admissions, according to research published in JCO Oncology Practice.

At least 600 employees at the US Centers for Disease Control and Prevention received permanent termination notices last week.

The FDA has authorized the ArteraAI Prostate Test to prognosticate long-term outcomes in patients with non-metastatic prostate cancer.

This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

The National Institutes of Health (NIH) can continue withholding funding for terminated research grants, the Supreme Court has ruled. 1,2 The court’s decision allows the NIH to withhold the funding ...

Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.

The “early promising clinical outcomes” provide a strong basis for further investigation of upright image-guided adaptive proton therapy, according to researchers.

The main implication of our study is support for incorporating quadruplet regimens into new guidelines for the management of transplant-ineligible patients newly diagnosed multiple myeloma,” the ...

An analysis of more than 13 million EHR notes revealed evidence suggesting racial bias in how doctors document patient credibility.